Predictive signatures for chemotherapy sensitivity in breast cancer: Are they ready for use in the clinic?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference48 articles.
1. International web-based consultation on priorities for translational breast cancer research;Dowsett;Breast Cancer Res,2007
2. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003
3. HER2 and response to paclitaxel in node-positive breast cancer;Hayes;N Engl J Med,2007
4. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer;Berry;JAMA,2006
5. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials;De Laurentiis;J Clin Oncol,2008
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival;Breast Cancer;2020-09-20
2. Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells;Phytomedicine;2015-01
3. Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?;Annals of Oncology;2014-06
4. Molecular tests as prognostic factors in breast cancer;Virchows Archiv;2014-02-01
5. Ki67 Index in Breast Cancer: Correlation with Other Prognostic Markers and Potential in Pakistani Patients;Asian Pacific Journal of Cancer Prevention;2013-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3